info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Asia Pacific Orthopedic Biometrial Market Share

ID: MRFR//0200-HCR | 50 Pages | Author: Rahul Gotadki| November 2024

A lot of people are buying medical biomaterials in Asia and the Pacific. This is because more and more people are having problems with their joints and they want new medical technology. Businesses in the market use smart location to get an edge over their rivals in a world that is always growing and shifting.
Research and development should be backed with a lot of money. This will help people come up with new ideas in orthopedic polymers. Companies want to be on the cutting edge of new technology, so they work hard to make cutting-edge materials that are better at adapting to living things, lasting longer, and growing back.
Companies work hard to add more biomaterial goods to their lines so they can meet the needs of the medical market's wide range of needs. The things that are being made for joint replacements, bone grafts, and tissue engineering are in this group. With a lot of goods, a company can handle a lot of different medical uses. This helps them do better in the market.
It's very important to have smart relationships with study groups, medical doctors, and health care institutions in order to get into the market. Companies can get more involved in the medical community and work closely with key thought leaders to learn more about clinical needs. This will help them make better products, learn more about what doctors need, and eventually grow their market share.
There are a lot of different healthcare systems in the Asia-Pacific region, so businesses are working to reach more people to better serve their clients. This will only work if businesses work together, set up shipping systems, and build plants in new areas so they can quickly enter new markets and serve a wide range of customers.
To get ahead in the market, one of the most important things you can do is make sure that the orthopedic plastics you pick are acceptable to the people in your area. Businesses change the things they sell to meet the wants of their customers and the way treatment is given in the area. This makes sure that their plastics are accepted in many places in the Asia-Pacific region.
Being sure to follow the law and promise quality are important for building trust in a business. Companies have to spend a lot of money to follow the rules and get the right certifications. This is to make sure that their polymers for orthopedics are safe and work well.
Companies spend money on programs that teach and train people who work in the healthcare field so that it is easy for them to use new substances. These classes have helped people learn more about knee plastics and how they can help them. This makes people feel better, which has an effect on market share.
There are low-cost ways for companies in the Asia-Pacific region to make it easy for people to get medical plastics. This is the case because the businesses in this area are so different. Some ways to do this are to set fair prices, work together with healthcare providers in smart ways, and start programs that aim to lower patients' overall treatment costs.
Businesses are beginning to use more eco-friendly methods in their daily work as more people think about the earth. To do this, eco-friendly materials must be used, production waste must be cut down, and long-lasting methods must be set up for the whole supply chain. This changes how the market sees the company, which makes people who care about the world happy.
If you want to keep people happy and coming back, you should have a good way to help them after the sale. People who work for healthcare companies are taught the right way to use and give medical plastics. This works best and makes the business look better in the eyes of the outside world.
You need to know about the market and study facts in order to make smart choices. A company will study data to find out more about its rivals, its customers, and how the market is changing. There is always new competition in the Asia-Pacific knee biomaterial market, so they can change their plan to stay ahead.

Covered Aspects:

Report Attribute/Metric Details
Base Year For Estimation   2021
Forecast Period   2022-2030
Growth Rate   10.5%

Asia Pacific Orthopedic Biomaterial Market Overview


Asia Pacific Orthopedic Biometrial Market Size was valued at USD 22.67 Billion in 2023. The Asia Pacific Orthopedic Biometrial industry is projected to grow from USD 23.88 Billion in 2024 to USD 42.23 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.64% during the forecast period (2024 - 2032). Orthopedic biomaterials are organic or synthetic materials used for the treatment of internal fractures. During the last decade different new techniques and materials are introduced for orthopedic implants and surgeries and biomaterials have found a vital role in it. 


These biomaterials are used in manufacturing of different implants since they do not evoke any immunological reactions with the body, which makes it a first choice for manufacturing of implants. Increasing demand for the orthopedic biomaterial because of its application in knee and hip replacement surgeries, and increasing incident of medical emergencies drive the Asia Pacific orthopedic biomaterial market.


Introduction of novel implants of titanium has increased the success rate of implant surgeries and also contributed to the growth of the orthopedic market in Asia Pacific. Moreover, increasing number of orthopedic surgeries, increasing aging population, and growing governmental support also drive the Asia Pacific market. However, increasing failure in joints implants, stringent regulatory laws, and high cost of treatment may hinder the growth of Asia Pacific orthopedic biomaterial market during the review period.


Orthopedic biomaterials might be artificial or natural. They are made to be inserted into a person's body as parts of machines that are intended to carry out certain biological tasks by replacing or mending various tissues. Orthopedic biomaterials are utilized for tissue fixation, spine implants, joint replacements, and other orthopedic procedures. Additionally, the need for next-generation orthopedic biomaterials specifically designed to fulfill the requirements of a particular orthopedic operation is on the rise globally. On the other hand, the market's expansion has been hampered by the restricted payment coverage alternatives for these devices and the falling reimbursement for orthopedic implants in several nations. Additionally, the lack of rebates has forced suppliers to reduce the cost of these products, which has slowed market expansion.


The growing geriatric population, rising incidence rates of accidents and sports-related injuries, rising awareness of orthopedic biomaterials, and introduction of novel products by major market players are a few of the factors anticipated to boost market growth over the forecast period. Fewer traffic accidents and injuries occurred due to the pandemic's widespread lockdowns, curtailing private and public transit. As a result, the focus of healthcare institutions shifted from operations to COVID-19 patients. This immediately affected the market during the early pandemic phase, especially in specialist hospitals. Increased bone fractures, disc degenerative disorders, and more trauma cases are predicted to increase product demand in this market. Due to factors like the rising geriatric population, increasing incidence rates of accidents and sports-related injuries, and rising awareness of orthopedic biomaterials.


CitrefixTM, a suture anchor system for surgical procedures on the foot and ankle, was introduced by Stryker. The new technology uses CitregenTM, a highly acclaimed bioresorbable substance created to imitate the composition and structure of natural bone. Citrefix is a resorbable, bio-inspired suture anchor system for single-use sutures. Citregen, an elastomeric substance formed from a citrate polymer and specifically created to imitate bone chemistry for regulated resorption without persistent inflammation, is used in its construction. These special chemical and mechanical qualities are intended to promote healthy bone growth and heal transplanted tissue when used in orthopedic surgical procedures.


Asia Pacific Orthopedic Biomaterial Market Key Players


Some of the major players in Asia Pacific orthopedic biomaterial market: 



  • Kyocera Corporation (Japan)

  • Materion Corporation (US)

  • S&V Technologies (Germany)

  • Rayner (UK), InVision Biomedical (US)

  • Covestro (Germany)

  • Invibio Ltd. (U.K.)

  • Royal DSM (Netherlands)

  • BASF SE (Germany)

  • Corbion N.V. (Netherlands)

  • CeramTec (Germany)

  • Tianjin Walkman Biomaterial Co. (China)

  • Kanghui Holdings (China)

  • Johnson & Johnson Services, Inc. (US)

  • Cam Bioceramics B.V. (Netherland)

  • Xian Airfoil Technology Co (China)


Asia Pacific Orthopedic Biomaterial Market Segmentation


The orthopedic biomaterials market is segmented on the basis of types of material, applications, and end users. On the basis of types of material, the market is segmented into metals and non-metals.  The metals are further segmented into stainless steel, titanium alloy, cobalt alloy, and others. Non-metal are further segmented into ceramic, polymeric, natural biomaterials, and others. The ceramic are sub-segmented into alumina, calcium phosphate, zirconium dioxide, carbon, and others. The polymeric materials are sub-segmented into polymethylmethacrylate (PMMA), polyethylene, silicone, polyester, and other. The natural biomaterials are sub-segmented into collagen, chitin & chitosan, and other


On the basis of applications, the Asia Pacific orthopedic biomaterial market is segmented into joint replacement, fracture fixation devices, tissue fixation, spine implants, viscosupplementation, and other. Joint replacement is sub-segmented into hip replacement, knee replacement, shoulder and elbow replacement, and other. Tissue fixation is sub-segmented into interference screws, suture anchors, and others. Spine implants are further sub-segmented into spine fusion and other. The fracture fixation devices are sub segmented into screws, plates for bones, rods, and other.


On the basis of end users, the Asia Pacific orthopedic biomaterial market is segmented into hospital, clinics, and others.The first surgical application of Acuitive Technologies, Inc.'s (Acuitive) Citrelock® ACL Tendon Fixation Device was disclosed. The novel ACL device offers orthopedic surgeons a unique design thanks to a tendon-friendly spiral thread made of Citregen, a next-generation resorbable material with special molecular and mechanical characteristics. With its cutting-edge material technology and distinctive design, the Citrelock ACL Tendon Fixation Device contributes to meeting this therapeutic requirement. The Citrelock ACL System is an exciting new addition to Acuitive's line of products and the first of many that we will be releasing with an emphasis on the sports medicine sector.


Asia Pacific Orthopedic Biomaterial Market Regional Analysis


China dominates the Asia Pacific orthopedic biomaterial market owing to increasing prevalence of different orthopedic surgeries in China. Increasing awareness of biodegradable products among the people, rapid research and development and huge aging population in this region have added fuel to the growth of the market. Japan and Australia are other major contributor of the Asia Pacific orthopedic biomaterial market in this region. 


Intended Audience



  • Product manufacturers

  • Biomaterial manufacturer

  • Research and development (R&D) companies

  • Hospitals and laboratories

  • Medical research laboratories

  • Academic medical institutes and universities

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.